Demographics of patients diagnosed with primary mediastinal lymphoma and thymic epithelial tumors in this study
| Pathological subtypes | N | Age | Age range | Male (%) |
|---|---|---|---|---|
| Primary mediastinal lymphoma | 71 (52.2%) | 30.25 ± 14.44 | 3–70 | 22 (31.0) |
| Classic Hodgkin lymphoma | 26 | 26.19 ± 9.82 | 6–50 | 23.1 |
| Diffuse large B-cell lymphoma | 30 | 36.43 ± 14.1 | 15–70 | 30.0 |
| T-lymphoblastic lymphoma | 9 | 19.33 ± 16.9 | 3–46 | 55.6 |
| Other types | 6 | 33.33 ± 16.86 | 13–59 | 33.3 |
| Thymic epithelial tumors | 65 (47.8%) | 54.23 ± 15.16 | 12–77 | 40 (61.5) |
| Thymoma_A | 4 | 64.75 ± 7.41 | 55–73 | 50.0 |
| Thymoma_AB | 4 | 57.00 ± 9.13 | 46–68 | 50.0 |
| Thymoma_B1 | 8 | 53.88 ± 12.51 | 41–76 | 62.5 |
| Thymoma_B2 | 6 | 52.5 ± 21.67 | 16–72 | 66.7 |
| Thymoma_B3 | 4 | 48.75 ± 13.3 | 33–64 | 75.0 |
| Thymic carcinomas | 39 | 53.77 ± 15.97 | 12–77 | 61.5 |
| Squamous cell carcinoma | 26 | 55.19 ± 15.48 | 12–76 | 61.5 |
| Neuroendocrine carcinoma | 8 | 58.25 ± 17.43 | 26–77 | 62.5 |
| Adenocarcinoma/sarcoma | 5 | 39.2 ± 8.58 | 24–45 | 60.0 |
| Total | 136 | 41.57 ± 19.12 | 3–77 | 62 (45.6) |